204 companies | 885 medical products
The Acusera SARS-CoV-2 Antibody Control comprises both reactive and non-reactive controls for anti SARS-CoV-2, and will support assay validation and routine performance monitoring of serological assays for COVID-19. Conveniently supplied in a liquid ready-to-use format with a 30-day open vial stability, waste is kept to a minimum. As a true third party control, independent performance assessment is guaranteed.
Confiscope G20 is a portable colorimetric analyzer for the automated reading and interpretation of GenBody immunochromatographic rapid tests. The instrument uses photometry to detect visual markers that result from the immunological reaction between the reagents and the specimen. It is intended to be used by health professionals for rapid in vitro diagnostic measurements at the point-of-care or in the laboratory.
The SARS-CoV-2 IgG II Quant assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative and quantitative determination of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Alinity and ARCHITECT i Systems. The assay is to be used as an aid in the diagnosis of SARS-CoV-2 infection in conjunction with clinical presentation and other laboratory tests. The assay is also to be used as an aid in evaluating immune status of infected individuals and to monitor antibody response in individuals that have received the COVID-19 vaccine, by quantitatively measuring IgG antibodies against the spike receptor-binding domain (RBD) of SARS-CoV-2.